Health Care: Drugs

Albany Molecular Research Inc (AMRI: NASDAQ)

$15.49 0.44 | 2.92%
02/10/16 - 03:59 PM ET
Company Cash Flow
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -3.28M 12.68M -3.78M 0.00
Operating Gains/Losses -1.12M 234.00K 176.00K 83.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -10.20M -9.33M -13.57M 2.73M
(Increase) Decrease in Inventories -7.97M -5.14M -2.21M 215.00K
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -4.87M 7.70M 196.00K -11.95M
(Decrease) Increase In Other Current Liabilities -5.84M 3.59M 0.00 0.00
(Increase) Decrease In Other Working Capital 1.05M -2.60M 1.94M -5.34M
Other Non-Cash Items 11.39M 3.98M 10.42M -8.19M
Net Cash From Continuing Operations 1.91M 28.18M 15.34M -1.48M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.91M 28.18M 15.34M -1.48M
Sale of Property, Plant & Equipment 80.00K 300.00K 447.00K 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -17.59M -11.55M -10.44M -11.26M
Acquisitions -145.75M 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 -817.00K
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -163.26M -11.25M -9.78M 3.97M
Issuance of Debt 35.00M 150.00M 5.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 2.31M 24.63M 531.00K 671.00K
Repayment of Long-Term Debt -5.06M -775.00K -2.84M -7.37M
Repurchase of Capital Stock -579.00K -164.00K 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 1.57M -36.80M -5.23M -270.00K
Net Cash From Financing Activities 33.24M 136.88M -2.53M -6.97M
Effect of Exchange Rate Changes -820.00K -1.18M 288.00K -1.28M
Net Change in Cash & Cash Equivalents -128.93M 152.63M 3.31M -5.76M

Portfolios with AMRI

Latest AMRI Headlines from TheStreet

More Financial News for AMRI

Press Releases for AMRI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter